Saladax Biomedical Inc.
Clozapine drug level results rapid enough to be of clinical benefit
Clozapine drug level results rapid enough to be of clinical benefit
Saladax Biomedical is a biotechnology company founded in 2004 that operates within the Biotechnology and Health Care industries. Their last investment was a $100.00K grant investment received on 22nd June 2020 from Ben Franklin Technology Partners of Northeastern Pennsylvania.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $100.00K | 1 |
|
22 Jun 2020 |
| Private Equity Round | $22.40M | 1 | Fosun Pharma | 05 Mar 2013 |
| Debt Financing | $9.00M | 1 |
|
21 Jun 2011 |
| Series C | $8.40M | 3 |
|
30 Mar 2010 |
| Series B | $7.92M | 1 |
|
02 Oct 2009 |
No recent news or press coverage available for Saladax Biomedical Inc..
We care about your data, and we'd love to use cookies make your experience better.
